- Academic Registry
Programme & Unit Catalogues


BB50245: Advances in molecular medicine

[Page last updated: 02 August 2022]

Academic Year: 2022/23
Owning Department/School: Department of Biology & Biochemistry
Credits: 20 [equivalent to 40 CATS credits]
Notional Study Hours: 400
Level: Masters UG & PG (FHEQ level 7)
Period:
Academic Year
Assessment Summary: CW 50%, EX 40%, OT 10%
Assessment Detail:
  • Online Tests on Core Knowledge (OT 10%)
  • Research Paper Seminar Presentation (CW 20%)
  • Literature Review (2000-3000 words) (CW 30%)
  • Synoptic Written Examination (EX 40%)
Supplementary Assessment:
Like-for-like reassessment (where allowed by programme regulations)
Requisites:
Learning Outcomes: By the end of this unit you will be able to:
* Apply your understanding of your core molecular medicine knowledge drawing on concepts in the molecular and cellular basis of disease
* Critically evaluate and communicate the findings of a cutting-edge molecular medicine research publication through a formal presentation
* Critically evaluate, synthesise and summarise the findings of a variety of cutting-edge molecular medicine research publications through a written literature review
* Demonstrate an integrative and evaluative approach to addressing some of the challenges and opportunities in treating human diseases.

Aims: The unit is aimed at synthesising and advancing our knowledge of how molecular, cellular and genetic / epigenetic processes regulate human health and disease.

Content: This unit is aimed at synthesising and advancing our knowledge of how molecular, cellular and genetic / epigenetic processes regulate human health and disease. Topics will include:
* molecular genetics/epigenetics of cancer, diabetes, stem cell reprogramming, medical neuroscience, immunology and epidemiology of infections.
* Molecular approaches used to develop interventions (genomics for vaccine and chemotherapeutic target identification, Next Generation Sequencing, epidemiology and prediction, regenerative medicine, personalised medicine).

Programme availability:

BB50245 is a Designated Essential Unit on the following programmes:

Department of Biology & Biochemistry
  • RSBB-AFM50 : Integrated PhD Molecular Biosciences (Medical Biosciences)
  • TSBB-AFM50 : MSc Molecular Biosciences (Medical Biosciences)

Notes:

  • This unit catalogue is applicable for the 2022/23 academic year only. Students continuing their studies into 2023/24 and beyond should not assume that this unit will be available in future years in the format displayed here for 2022/23.
  • Programmes and units are subject to change in accordance with normal University procedures.
  • Availability of units will be subject to constraints such as staff availability, minimum and maximum group sizes, and timetabling factors as well as a student's ability to meet any pre-requisite rules.
  • Find out more about these and other important University terms and conditions here.